Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Welch, H. G.
space
  arrow  Black, W. C.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

Using Autopsy Series To Estimate the Disease "Reservoir" for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?

right arrow H. Gilbert Welch, MD, MPH, and William C. Black, MD

1 December 1997 | Volume 127 Issue 11 | Pages 1023-1028

Purpose: To determine how many cases of breast cancer might be found if women not known to have the disease were thoroughly examined (the disease "reservoir").

Data Sources: MEDLINE search from 1966 to the present.

Study Selection: Hospital-based and forensic autopsy series examining women not known to have had breast cancer during life.

Data Extraction: Observed prevalence of occult invasive breast cancer or ductal carcinoma in situ (DCIS) in which the number of women who were given a diagnosis was the numerator and the number of women examined was the denominator. For each autopsy series, we attempted to ascertain the level of scrutiny (sampling method, number of slides examined) given to the pathologic specimens.

Data Synthesis: Among seven autopsy series of women not known to have had breast cancer during life, the median prevalence of invasive breast cancer was 1.3% (range, 0% to 1.8%) and the median prevalence of DCIS was 8.9% (range, 0% to 14.7%). Prevalences were higher among women likely to have been screened (that is, women 40 to 70 years of age). The mean number of slides examined per breast ranged from 9 to 275; series that reported higher levels of scrutiny tended to discover more cases of cancer.

Conclusions: A substantial reservoir of DCIS is undetected during life. How hard pathologists look for the disease and, perhaps, their threshold for making the diagnosis are potentially important factors in determining how many cases of DCIS are diagnosed. The latter has important implications for what it means to have the disease.

Author and Article Information
space

From the Department of Veterans Affairs Medical Center, White River Junction, Vermont; Dartmouth Medical School, Hanover, New Hampshire; and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Acknowledgments: The authors thank Rick Haver, Chief of the Library Service, Department of Veterans Affairs Medical Center, White River Junction, Vermont, for performing the literature searches; Roger Goldstein for assistance in obtaining the articles; and Robert Pritchard, MD, Lisa Schwartz, MD, Wendy Wells, MD, and Steve Woloshin, MD, for thoughtful comments on the manuscript.
Grant Support: Dr. Welch was supported by a Veterans Affairs Career Development Award in health services research and development.
Requests for Reprints: H. Gilbert Welch, MD, MPH, VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction, VT 05009.
Current Author Addresses: Dr. Welch: VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction, VT 05009.


Related articles in Annals:

Reviews
Ductal Carcinoma in Situ of the Breast
Rafael Fonseca, Lynn C. Hartmann, Ivy A. Petersen, John H. Donohue, Thomas B. Crotty, AND John J. Gisvold
Annals 1997 127: 1013-1022. [ABSTRACT][Full Text]  

Perspectives
Lessons from the Mammography Screening Controversy: Can We Improve the Debate?
David F. Ransohoff AND Russell P. Harris
Annals 1997 127: 1029-1034. [ABSTRACT][Full Text]  

Articles
Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age
Peter Salzmann, Karla Kerlikowske, AND Kathryn Phillips
Annals 1997 127: 955-965. [ABSTRACT][Full Text]  

Articles
The Role of Numeracy in Understanding the Benefit of Screening Mammography
Lisa M. Schwartz, Steven Woloshin, William C. Black, AND H. Gilbert Welch
Annals 1997 127: 966-972. [ABSTRACT][Full Text]  

Articles
The Role of Hormone Replacement Therapy in the Risk for Breast Cancer and Total Mortality in Women with a Family History of Breast Cancer
Thomas A. Sellers, Pamela J. Mink, James R. Cerhan, Wei Zheng, Kristin E. Anderson, Lawrence H. Kushi, AND Aaron R. Folsom
Annals 1997 127: 973-980. [ABSTRACT][Full Text]  



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
K. B. Horwitz
Commentary: The Year in Basic Science: Update of Estrogen Plus Progestin Therapy for Menopausal Hormone Replacement Implicating Stem Cells in the Increased Breast Cancer Risk
Mol. Endocrinol., December 1, 2008; 22(12): 2743 - 2750.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. M. Kaplan and F. Porzsolt
The Natural History of Breast Cancer
Arch Intern Med, November 24, 2008; 168(21): 2302 - 2303.
[Full Text] [PDF]


Home page
RadiologyHome page
P. Loubeyre, P. Petignat, and F. M. Hall
Is the Field of Breast Imaging Moving toward Broader Use of MR Imaging?
Radiology, November 1, 2008; 249(2): 721 - 722.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. B. Horwitz and C. A. Sartorius
Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3295 - 3298.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Willimsky, M. Czeh, C. Loddenkemper, J. Gellermann, K. Schmidt, P. Wust, H. Stein, and T. Blankenstein
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
J. Exp. Med., July 7, 2008; 205(7): 1687 - 1700.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. G. Welch, S. Woloshin, and L. M. Schwartz
The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ--The Price of Screening Mammography
J Natl Cancer Inst, February 20, 2008; 100(4): 228 - 229.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. A. de Roos, B. van der Vegt, J. de Vries, J. Wesseling, and G. H. de Bock
Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast
Ann. Surg. Oncol., July 1, 2007; 14(7): 2097 - 2104.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
D. G. Fryback, N. K. Stout, M. A. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, and P. L. Remington
Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 37 - 47.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
K. J. Jorgensen and P. C Gotzsche
Content of invitations for publicly funded screening mammography.
BMJ, March 4, 2006; 332(7540): 538 - 541.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. M. Geiger, O. Yu, L. J. Herrinton, W. E. Barlow, E. L. Harris, S. Rolnick, M. B. Barton, J. G. Elmore, and S. W. Fletcher
A Population-Based Study of Bilateral Prophylactic Mastectomy Efficacy in Women at Elevated Risk for Breast Cancer in Community Practices
Arch Intern Med, March 14, 2005; 165(5): 516 - 520.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
H. BERMAN, J. ZHANG, Y.G. CRAWFORD, M.L. GAUTHIER, C.A. FORDYCE, K.M. McDERMOTT, M. SIGAROUDINIA, K. KOZAKIEWICZ, and T.D. TLSTY
Genetic and Epigenetic Changes in Mammary Epithelial Cells Identify a Subpopulation of Cells Involved in Early Carcinogenesis
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 317 - 327.
[Abstract] [PDF]


Home page
JAMAHome page
H. Joensuu, T. Lehtimaki, K. Holli, L. Elomaa, T. Turpeenniemi-Hujanen, V. Kataja, A. Anttila, M. Lundin, J. Isola, and J. Lundin
Risk for Distant Recurrence of Breast Cancer Detected by Mammography Screening or Other Methods
JAMA, September 1, 2004; 292(9): 1064 - 1073.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
I S Cook and C E Fuller
Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?
J. Clin. Pathol., March 1, 2004; 57(3): 286 - 289.
[Abstract] [Full Text] [PDF]


Home page
J Health PsycholHome page
R. M. Kaplan, T. G. Ganiats, and D. L. Frosch
Diagnostic and Treatment Decisions in US Healthcare
J Health Psychol, January 1, 2004; 9(1): 29 - 40.
[Abstract] [PDF]


Home page
NEJMHome page
S. W. Fletcher and J. G. Elmore
Mammographic Screening for Breast Cancer
N. Engl. J. Med., April 24, 2003; 348(17): 1672 - 1680.
[Full Text] [PDF]


Home page
Cancer Res.Home page
C. R. Holst, G. J. Nuovo, M. Esteller, K. Chew, S. B. Baylin, J. G. Herman, and T. D. Tlsty
Methylation of p16INK4a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia
Cancer Res., April 1, 2003; 63(7): 1596 - 1601.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al.
Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. M. Schwartz and S. Woloshin
News Media Coverage of Screening Mammography for Women in Their 40s and Tamoxifen for Primary Prevention of Breast Cancer
JAMA, June 19, 2002; 287(23): 3136 - 3142.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. G. Welch
Informed Choice in Cancer Screening
JAMA, June 6, 2001; 285(21): 2776 - 2778.
[Full Text] [PDF]


Home page
BMJHome page
L. M Schwartz, S. Woloshin, H. C Sox, B. Fischhoff, and H G. Welch
US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey
BMJ, June 17, 2000; 320(7250): 1635 - 1640.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
S. Y. Moody-Ayers, C. K. Wells, and A. R. Feinstein
"Benign" Tumors and "Early Detection" in Mammography-Screened Patients of a Natural Cohort With Breast Cancer
Arch Intern Med, April 24, 2000; 160(8): 1109 - 1115.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
V. L. Ernster, J. Barclay, K. Kerlikowske, H. Wilkie, and R. Ballard-Barbash
Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program
Arch Intern Med, April 10, 2000; 160(7): 953 - 958.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. B. Barton, R. Harris, and S. W. Fletcher
Does This Patient Have Breast Cancer?: The Screening Clinical Breast Examination: Should It Be Done? How?
JAMA, October 6, 1999; 282(13): 1270 - 1280.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.